Search results

Narrow your search

Result types

Showing 301 - 310 of 684 for "J Sagar Associates" with applied filters

News & Analysis

Biological Material and Written Description Requirement under Patent Law

29 January 2024 by DPS Parmar (Special Counsel)

The three tenets of a patent grant are possession, disclosure, and claims of invention.

News & Analysis

Quid Pro Quo of Patent Bargain: Disclosure of Invention

16 January 2024 by Manisha Singh (Partner) & Vaneet Kaur (Managing Associate)

The exclusive right of a patentee to stop others from making or using their invention for a defined period is balanced by the obligation to disclose the invention in detail.

News & Analysis

First Insights into China’s New Corporate Landscape

05 January 2024 by Ray SHI, Claire XU

Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).

News & Analysis

Anatomy of Licensing Deals from China Regulatory Perspective

04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU

Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.

News & Analysis

ESG Banking Products in China — (I) Green Deposits

03 January 2024 by Ting ZHENG, Raymond YAN, Eryin YING, Lin ZHU

ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China

News & Analysis

Sponsored briefing: The foreign acquisition of Chinese enterprises

03 January 2024 by Hui Ye Law Firm - China

Wu Dong of Hui Ye Law Firm discusses the key points necessary for understanding the foreign acquisition of Chinese state-owned enterprises

News & Analysis

Roche v DCGI: Delhi High Court on Rejection of Plaints and Doctrine of Passing Off

21 December 2023 by Manisha Singh (Partner) & Neha Ruhela (Senior Associate)

The Delhi High Court, in F Hoffmann-La Roche & others v. Drugs Controller General of India & others (2023:DHC:6522), dismissed applications filed by Cadila Healthcare and Hetero Drugs seeking rejection of the plaints in Roche’s suits

News & Analysis

VILAF announces promotion of new partner Tung Nguyen

15 December 2023 by VILAF - Vietnam

VILAF announces promotion of new partner Tung Nguyen

News & Analysis

Designing around patent is considered legitimate

13 December 2023 by DPS Parmar

It is common to find competitive inventors to work on the uncovered aspect of a patent claim and design around it to escape the sword of infringement.

News & Analysis

Effects of the Draft Patent Rules, 2023 on Pharma Industry

30 November 2023 by Manisha Singh (Partner) & Harshini A. (Trainee Associate)

A couple of months back, the Ministry of Commerce and Industry published the Draft Patents (Amendment) Rules,2023, with various changes to the rules, regulations and fees, which welcomed suggestions and objections from the public.